The Urticaria Severity Score: a sensitive questionnaire/index for monitoring response to therapy in patients with chronic urticaria

Jariwala, Sunit; Moday, Heather; Asis, Marzieh; Fodeman, Jason; Hudes, Golda; Vos, Gabriele de; Rosenstreich, David L.

doi:10.1016/s1081-1206(10)60120-2

Cited by 36 publications

(27 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Patient characteristics data and basic laboratory tests were completed at the first visit. Severity of urticaria was measured by urticaria severity score (USS) that was included with 12 questions and 7 response options per question included in the final questionnaire [18]. The dermatology life quality index (DLQI) is a common test used as a quality of life measure [19].…”

Section: Methodsmentioning

confidence: 99%

Autologous serum and plasma skin test to predict 2-year outcome in chronic spontaneous urticaria

Boonpiyathad

Sangasapaviliya

2016

Asia Pacific Allergy

View full text Add to dashboard Cite

BackgroundAutologous serum skin test (ASST) and autologous plasma skin test (APST) are simple methods to diagnose autoimmune chronic urticaria. However, the association data of ASST or APST with disease severity and long-term outcome are still unclear.ObjectiveThe results of ASST and APST might be used to predict urticaria symptom severity and long-term outcomes among chronic spontaneous urticaria (CSU) patients.MethodsWe evaluated the prevalence of reactive ASST and APST in 128 CSU patients. The patients were characterized by 4 groups: negative, ASST positive, APST positive, and both ASST and APST positive. We observed remission rate among the CSU patients during 2 years.ResultsForty-four of 128 CSU patients (34%) had negative autologous skin test. The CSU patients with positive ASST, positive APST, and both positive ASST and APST were 47 (37%), 6 (5%), and 31 (24%), respectively. No significant difference was found between the groups according to urticaria severity score (USS) and dermatology life quality index (DLQI). Mean wheal diameter of ASST showed positive correlation with DLQI. Also, mean wheal diameter of APST showed positive correlation with USS and DLQI. Both the positive ASST and APST groups had a high proportion of 4-fold dose of H1-antihistamine than the positive ASST (p = 0.03) and negative groups (p = 0.0009). The rate of remission over 2 years in the negative, positive ASST, positive APST, and both positive ASST and APST groups were 81.1%, 62.3%, 60%, and 46.1%, respectively. The urticaria remission rate in patients in the negative group was significantly higher compared with both positive ASST and APST groups (odds ratio, 5.0; 95% confidence interval, 1.61–15.44; p = 0.006).ConclusionASST and APST results could predict remission rates among patients with CSU. Our results suggested investigating ASST and APST among CSU patients before starting treatment.

show abstract

Section: Methodsmentioning

confidence: 99%

Autologous serum and plasma skin test to predict 2-year outcome in chronic spontaneous urticaria

Boonpiyathad

Sangasapaviliya

2016

Asia Pacific Allergy

View full text Add to dashboard Cite

show abstract

“…Kako je klinička slika urtikarije promjenljiva, njenu aktivnost je najbolje mjeriti svakodnevno, te se savjetuje bolesnicima da dokumentuju procjenu bolesti, tj. da vrše samoocjenjivanje tokom 24 sata [14]. Komparirali smo težinu kliničke slike, kao i efekat primijenjene terapije mjerene USS skorom, te dužinu trajanja urtikarije.…”

Section: Metode Radaunclassified

“…Jariwala i sar. [14] navode da osim upitnika o kvalitetu života (DLQI) postoji potreba za validnijim instrumentom za procjenu i praćenje bolesnika sa hroničnom urtikarijom. U studiji od 80 bolesnika sa hroničnom urtikarijom upoređivao je USS i upitnik kvaliteta života, Dermatology Life Quality Index (DLQI), nakon praćen-ja bolesnika u trajanju od oko dvije nedjelje.…”

Section: Diskusijaunclassified

Primjena autohemoterapije u liječenju hronične urtikarije

Baroš¹,

Gajanin²,

Sladojević³

et al. 2017

BII

View full text Add to dashboard Cite

Kratak sadržajUvod. U liječenju hronične urtikarije, osim standardnih protokola, može biti efikasna i primjena autohemoterapije. Cilj rada je utvrditi uspješnost autohemoterapije u liječenju hronične autoimunske urtikarije na težinu bolesti i prosječnu dužinu trajanja hronične urtikarije kod pacijenata liječenih u našoj ustanovi.Metode. Ispitivana su 64 bolesnika sa hroničnom urtikarijom tokom šest nedjelja. Ispitanici su podijeljeni u dvije grupe: 28 bolesnika sa autoimunskom hroničnom urtikarijom kojima su ordinirane standardna i autohemoterapija i 36 bolesnika sa idiopatskom hroničnom urtikarijom kojima je ordinirana samo standardna terapija. Terapijski uspjeh primjene autohemoterapije u liječenju hronične urtikarije smo pratili pomoću skora težine urtikarije (engl. Urticaria Severity Score -USS). Takođe, odredili smo prosječnu dužinu trajanja urtikarije. Za statističku analizu korišćeni su Mann-Whitney i Friedman-ov test, za nivo značajnosti razlike manje od 5%.Rezultati. Poređenjem vrijednosti USS utvrđena je statistički značajna razlika u visini nedjeljnog USS na početku i na kraju ispitivanja kod obje grupe bolesnika: kod bolesnika sa autoimunskom hroničnom urtikarijom (χ 2 = 122,130, p< 0,001) i kod bolesnika sa idiopatskom hroničnom urtikarijom (χ 2 = 137,827, p<0,001). Poređenjem vrijednosti USS između grupa bolesnika tokom prvih pet nedjelja praćenja nije utvrđena statistički značajna razlika. Međutim, u šestoj nedjelji je nađena statistički značajna razlika u USS između ispitivanih grupa (p = 0,032). Kod bolesnika sa autoimunskom hroničnom urtikarijom i idiopatskom hroničnom urtikarijom prosječna dužina trajanja urtikarije približno je iznosila 20 mjeseci i nema statistički značajne razlike u dužini trajanja urtikarije između grupa (p = 0,978).Zaključak. Autohemoterapija se pokazala efikasnom i uspješnom u liječenju autoimunske hronične urtikarije u odnosu na standardne protokole liječenja hronične urtikarije, ali ne utiče na dužinu trajanja urtikarije.

show abstract

“…The UAS7 is a validated tool for assessing disease activity in CSU and was already recommended to be used in routine clinical practice and clinical trials in the previous guideline. Recently another score, the Urticaria Severity Score (USS), has been developed and validated (9). The USS combines assessment of signs and symptoms with QoL questions.…”

Section: Should the Current Classification Be Maintained In Urticaria?mentioning

confidence: 99%

Methods report on the development of the 2013 revision and update of the EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria

Zuberbier

Aberer

Asero

et al. 2014

Allergy

View full text Add to dashboard Cite

This methods report describes the process of guideline development in detail. It is the result of a systematic literature review using the 'Grading of Recommendations Assessment, Development and Evaluation' (GRADE) methodology and a structured consensus conference held on 28 and 29 November 2012, in Berlin. It is a joint initiative of the Dermatology Section of the European Academy of Allergy and Clinical Immunology (EAACI), the EU-funded network of excellence, the Global Allergy and Asthma European Network (GA 2 LEN), the European Dermatology Forum (EDF), and the World Allergy Organization (WAO) with the participation of delegates of 21 national and international societies. This guideline covers the definition and classification of urticaria, taking into account the recent progress in identifying its causes, eliciting factors and pathomechanisms. In addition, it outlines evidence-based diagnostic and therapeutic approaches for the different subtypes of urticaria. This guideline was acknowledged and accepted by the European Union of Medical Specialists (UEMS) and is published in Allergy 2014; 69:868-887.Allergy 69 (2014) e1-e29

show abstract

The Urticaria Severity Score: a sensitive questionnaire/index for monitoring response to therapy in patients with chronic urticaria

Cited by 36 publications

References 20 publications

Autologous serum and plasma skin test to predict 2-year outcome in chronic spontaneous urticaria

Autologous serum and plasma skin test to predict 2-year outcome in chronic spontaneous urticaria

Primjena autohemoterapije u liječenju hronične urtikarije

Methods report on the development of the 2013 revision and update of the EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria

Contact Info

Product

Resources

About

The Urticaria Severity Score: a sensitive questionnaire/index for monitoring response to therapy in patients with chronic urticaria

Cited by 36 publications

References 20 publications

Autologous serum and plasma skin test to predict 2-year outcome in chronic spontaneous urticaria

Autologous serum and plasma skin test to predict 2-year outcome in chronic spontaneous urticaria

Primjena autohemoterapije u liječenju hronične urtikarije

Methods report on the development of the 2013 revision and update of the EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria

Contact Info

Product

Resources

About

Methods report on the development of the 2013 revision and update of the EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria